Maplelane Capital’s Affirm AFRM Stock Holding History

Maplelane Capital’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-85,000	Closed	-$4.18M	–	85
2023 Q4	$4.18M	Buy	+85,000	New	+$2.46M	0.19%	52

Other funds holding AFRM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Maplelane Capital's AFRM Position: Q1 2022 in Review

Maplelane Capital sold out of Affirm (AFRM) in Q1 2022, closing a stake of 50,000 shares — an estimated $5.03M sold.

Maplelane Capital first reported a position in AFRM in Q3 2021 and held it in 2 quarters. The position peaked at $10.6M in Q3 2021. 391 funds tracked by Wall St. Rank hold AFRM as of Q1 2022.

Maplelane Capital reported no remaining Affirm position as of Q1 2022 after selling out during the quarter.
Maplelane Capital sold 50,000 Affirm shares in Q1 2022, an estimated $5.03M.
Maplelane Capital first reported a position in Affirm in Q3 2021 and held it in 2 quarters.
Maplelane Capital's Affirm position peaked at $10.6M in Q3 2021.
391 funds tracked by Wall St. Rank held Affirm as of Q1 2022.

Based on Maplelane Capital's 13F filing for Q1 2022, filed 16 May 2022.